chr17-5432890-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001212.4(C1QBP):c.*125A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 1,131,202 control chromosomes in the GnomAD database, including 46,726 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 5787 hom., cov: 32)
Exomes 𝑓: 0.26 ( 40939 hom. )
Consequence
C1QBP
NM_001212.4 3_prime_UTR
NM_001212.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.05
Genes affected
C1QBP (HGNC:1243): (complement C1q binding protein) The human complement subcomponent C1q associates with C1r and C1s in order to yield the first component of the serum complement system. The protein encoded by this gene is known to bind to the globular heads of C1q molecules and inhibit C1 activation. This protein has also been identified as the p32 subunit of pre-mRNA splicing factor SF2, as well as a hyaluronic acid-binding protein. [provided by RefSeq, Jul 2008]
RPAIN (HGNC:28641): (RPA interacting protein) Predicted to enable metal ion binding activity. Acts upstream of or within several processes, including DNA metabolic process; protein import into nucleus; and response to UV. Located in PML body; cytoplasm; and fibrillar center. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 17-5432890-T-C is Benign according to our data. Variant chr17-5432890-T-C is described in ClinVar as [Benign]. Clinvar id is 1286412.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.778 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1QBP | NM_001212.4 | c.*125A>G | 3_prime_UTR_variant | 6/6 | ENST00000225698.8 | NP_001203.1 | ||
RPAIN | NM_001033002.4 | c.*319T>C | downstream_gene_variant | ENST00000381209.8 | NP_001028174.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1QBP | ENST00000225698.8 | c.*125A>G | 3_prime_UTR_variant | 6/6 | 1 | NM_001212.4 | ENSP00000225698.4 | |||
RPAIN | ENST00000381209.8 | c.*319T>C | downstream_gene_variant | 1 | NM_001033002.4 | ENSP00000370606.3 |
Frequencies
GnomAD3 genomes AF: 0.242 AC: 36699AN: 151776Hom.: 5786 Cov.: 32
GnomAD3 genomes
AF:
AC:
36699
AN:
151776
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.258 AC: 253033AN: 979308Hom.: 40939 Cov.: 13 AF XY: 0.264 AC XY: 128552AN XY: 487112
GnomAD4 exome
AF:
AC:
253033
AN:
979308
Hom.:
Cov.:
13
AF XY:
AC XY:
128552
AN XY:
487112
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.242 AC: 36730AN: 151894Hom.: 5787 Cov.: 32 AF XY: 0.254 AC XY: 18853AN XY: 74240
GnomAD4 genome
AF:
AC:
36730
AN:
151894
Hom.:
Cov.:
32
AF XY:
AC XY:
18853
AN XY:
74240
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2010
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at